Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 109.318 |
|
|||||
| News | - | ||||||
| Tageshoch | 3,2875 | Niedrig Hoch |
|||||
| Tagestief | 3,10 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Reviva Pharmaceuticals Holdings Inc | RVPH | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,02 | 0,63% | 3,20 | 22:30:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 3,21 | 3,10 | 3,2875 | 3,20 | 3,18 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 1.119 | 109.318 | US$ 3,18 | US$ 347.639 | - | 2,67 - 9,2499 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 22:00:01 | 19 | US$ 3,20 | USD |
Finanzwerte RVPH
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 198,19M | 22,65M | - | 0 | -39,26M | -1,73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Reviva Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 16.2.2024 | 22:32 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 14.2.2024 | 06:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 13.2.2024 | 23:00 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 02.2.2024 | 22:38 | Edgar (US Regulatory) | Form S-3 - Registration statement under Securities Act of.. |
| 17.11.2023 | 22:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.11.2023 | 22:03 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 14.11.2023 | 22:12 | Edgar (US Regulatory) | Form 8-K - Current report |
| 30.10.2023 | 13:20 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04.10.2023 | 23:03 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 04.10.2023 | 23:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 17.8.2023 | 12:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.8.2023 | 22:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Reviva Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
RVPH Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 2,97 | 3,30 | 2,90 | 3,06 | 102.351 | 0,23 | 7,74% |
| 1 Monat | 3,60 | 3,81 | 2,90 | 3,33 | 138.761 | -0,40 | -11,11% |
| 3 Monate | 4,35 | 4,83 | 2,67 | 3,63 | 257.613 | -1,15 | -26,44% |
| 6 Monate | 4,90 | 6,3001 | 2,67 | 4,22 | 405.316 | -1,70 | -34,69% |
| 1 Jahr | 7,24 | 9,2499 | 2,67 | 4,91 | 503.879 | -4,04 | -55,80% |
| 3 Jahre | 5,77 | 9,2499 | 0,53 | 3,58 | 430.491 | -2,57 | -44,54% |
| 5 Jahre | 9,46 | 9,61 | 0,53 | 4,69 | 493.536 | -6,26 | -66,17% |
